Valuation: HitGen Inc.

Market Cap 14.6B 2.19B 1.96B 1.81B 1.64B 3.06B 209B 3.11B 21.59B 8.61B 109B 8.22B 8.04B 346B P/E 2026 *
98.5x
P/E 2027 * 75.1x
Enterprise Value 14.6B 2.19B 1.96B 1.81B 1.64B 3.06B 209B 3.11B 21.59B 8.61B 109B 8.22B 8.04B 346B EV / Sales 2026 *
21.3x
EV / Sales 2027 * 17.1x
Free-Float
51.86%
Yield 2026 *
0.32%
Yield 2027 * 0.54%
1 day-0.05%
1 week-1.91%
Current month-18.48%
1 month-16.60%
3 months+28.91%
6 months+38.36%
Current year+55.35%
1 week 33.35
Extreme 33.35
37.96
1 month 33.35
Extreme 33.35
46.22
Current year 22.42
Extreme 22.42
47.58
1 year 21.46
Extreme 21.46
47.58
3 years 8.35
Extreme 8.35
47.58
5 years 8.35
Extreme 8.35
47.58
10 years 8.35
Extreme 8.35
61.99
Manager TitleAgeSince
Chief Executive Officer 63 01/06/2012
Director of Finance/CFO 56 27/04/2023
Investor Relations Contact 38 01/07/2019
Director TitleAgeSince
Chairman 63 01/06/2012
Director/Board Member 73 01/02/2012
Director/Board Member 65 24/03/2019
Date Insider Type Main position Quantity % Market Cap. Importance
9/22/26 A Buy

Chief Financial Officer

17,500 0.0044%
9/22/26 A Buy

Executive/Senior Manager

25,000 0.0062%
9/22/26 A Buy

Chief Executive Officer

94,000 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
-0.05%-1.91%+54.17%+152.11% 2.19B
+0.34%-3.03%+37.45%+61.06% 64.14B
+0.98%+2.26%+12.91%+82.98% 55.53B
+1.75%+2.76%+12.38%+103.69% 53.03B
-1.43%-1.17%+26.27%+52.86% 45.99B
-0.48%-2.80%+18.01%+117.99% 42.45B
+0.82%+1.37%+227.94%+922.41% 40.45B
-0.26%-4.20%+10.86%+45.18% 32.25B
-2.07%+44.58%+102.84%+88.74% 34.47B
-2.72%-8.79%+22.58%-5.63% 24.23B
Average -0.31%+3.27%+52.54%+162.14% 39.47B
Weighted average by Cap. -0.08%+3.10%+49.48%+160.83%

Financials

2026 *2027 *
Net sales 687M 103M 92.28M 85.14M 77.04M 144M 9.81B 146M 1.02B 405M 5.13B 387M 378M 16.26B 853M 128M 115M 106M 95.75M 179M 12.19B 182M 1.26B 504M 6.38B 481M 470M 20.21B
Net income 149M 22.31M 19.98M 18.43M 16.68M 31.19M 2.12B 31.7M 220M 87.74M 1.11B 83.72M 81.94M 3.52B 194M 29.13M 26.09M 24.07M 21.78M 40.73M 2.77B 41.39M 287M 115M 1.45B 109M 107M 4.6B
Net Debt - -
Projected Income Statement - Annual - HitGen Inc.
Logo HitGen Inc.
HitGen Inc is a China-based company primarily engaged in the research, development and optimization of small molecule and nucleic acid-based new drug candidates using deoxyribonucleic acid (DNA) encoded chemical library (DEL) technology. Through the drug discovery and optimization platform, the Company provides clients with services such as screening and optimization of designated biological targets, customized DEL design and synthesis, synthesis and modification of certain designated compounds or nucleic acids and related biological evaluation. The Company is also engaged in the transfer of rights and interests in new drug research projects, capital operations and marketing activities. The Company primarily operates its businesses in the domestic market and overseas markets, including the United States, France, the United Kingdom and Japan.
Employees
706
Date Price Change Volume
29/10/26 CN¥36.43 -0.05% 29,663,916
28/10/26 CN¥36.45 +8.84% 25,429,629
27/10/26 CN¥33.49 -5.07% 17,234,205
26/10/26 CN¥35.28 -4.85% 19,793,787
23/10/26 CN¥37.08 +5.34% 24,706,587
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - HitGen Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
36.43CNY
Average target price
43.60CNY
Spread / Average Target
+19.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - HitGen Inc.
  1. Stock Market
  2. Stocks
  3. 688222 Stock